Search
for
Sort by
Research 30 of 1000+
- Clinical and Biochemical Parameters of Androgen Action in Normal Healthy Caucasian<i>Versus</i>Chinese Subjects
- Diagnosis of hyperandrogenism: Biochemical criteria
- ADT-G as a promising biomarker for peripheral hyperandrogenism in adult female acne
- Serum 3α-androstanediol-glucuronide is decreased in nonhirsute women with acne vulgaris
- Is 3α, 17β-androstanediol-glucuronide a diagnostic marker in women with androgenic manifestations?
- Clinical relevance of testosterone and dihydrotestosterone metabolism in women
- Alterations in androgen conjugate levels in women and men with alopecia
- Plasma levels of C19 steroid glucuronides in pre-menopausal women with non-classical congenital adrenal hyperplasia
- Long-term physiological trends and their drivers: linking hair hormone concentrations with telemetry data in GPS-collared Serengeti wildebeest
- Urinary steroids in men with male-pattern alopecia
- Markers of peripheral androgen action in vivo and in vitro
- Alterations in androgen conjugate levels in women and men with alopecia
- PLASMA C19 STEROID SULPHATE LEVELS AND INDICES OF ANDROGEN BIOAVAILABILITY IN FEMALE PATTERN ANDROGENIC ALOPECIA
- Altered Hormone and Bioactive Lipid Plasma Profile in Rodent Models of Polycystic Ovarian Syndrome Revealed by Targeted Mass Spectrometry
- 3 alpha, 17 beta-androstanediol glucuronide in plasma. A marker of androgen action in idiopathic hirsutism.
- Quantitative analysis of 34 sex (pro)hormones, conjugates and bioactive oxidation products thereof in human plasma by GC- and LC-MS/MS and systematic investigation of overestimations of analyte concentrations not accounted for by method validation
- Oral contraceptives and risk of breast cancer in women aged 20–54 years
- The dose‐response of percutaneous oestradiol implants on the skeletons of postmenopausal women
- A comparison of cabergoline and bromocriptine in the treatment of hyperprolactinemic amenorrhea
- Overexpression of aldo-keto reductase 1C3 (AKR1C3) in LNCaP cells diverts androgen metabolism towards testosterone resulting in resistance to the 5α-reductase inhibitor finasteride
- Cutaneous Androgen Metabolism: Basic Research and Clinical Perspectives
- Characteristics of Men Who Report Persistent Sexual Symptoms After Finasteride Use for Hair Loss
- Lack of association between clinical and biochemical hyperandrogenism in patients with polycystic ovary syndrome
- In vivo and in vitro exposure to free fatty acids induce increased androgen production in animal models: a potential pathogenic factor of the polycystic ovary syndrome
- Idiopathic Hirsutism*
- What is the Rationale for Androgen Therapy for Women?
- Pharmakokinetik und Biokonversion von Dehydroepiandrosteron nach Dexamethason-Vorbehandlung bei Frauen mit dem Syndrom der polyzystischen Ovarien
- Prostate specific antigen (PSA) in diagnosis of polycystic ovarian syndrome – a new insight
- 5α-Reductase type 2 gene variant associations with prostate cancer risk, circulating hormone levels and androgenetic alopecia
- Effect of minoxidil on blood pressure and hemodynamics in severe hypertension